Related Experiment Video
Updated: Jun 26, 2025

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
Botulinum Toxin-A Infiltration to Control Post-Operative Pain after Mastectomy and Expander Reconstruction as
Giuseppe Andrea Ferraro1, Sara Mattiello2, Arcangelo Natriello3
1Multidisciplinary Department of Medical and Dental Specialties, University of Campania "Luigi Vanvitelli", 80138, Naples, Italy. giuseppe.ferraro@unicampania.it.
Botulinum toxin-A (BTX-A) may reduce painful spasms after breast reconstruction surgery. This review examines existing evidence on BTX-A for managing post-operative pain from sub-pectoral tissue expanders.
Area of Science:
- Plastic Surgery
- Neurotoxins
- Pain Management
Background:
- Sub-pectoral tissue expanders in breast reconstruction can cause painful pectoralis major muscle spasms.
- These spasms are a significant cause of post-operative pain and may necessitate early expander removal.
- Women undergoing post-mastectomy reconstruction report severe post-operative pain.
Purpose of the Study:
- To review the current evidence on the use of Botulinum toxin-A (BTX-A) for managing pain associated with sub-pectoral tissue expanders in breast reconstruction.
- To assess the efficacy of BTX-A in reducing pectoralis major muscle spasms and associated pain in this patient population.
Main Methods:
- Literature review of studies investigating BTX-A for pain relief in breast reconstruction.
- Analysis of evidence regarding BTX-A's mechanism in reducing muscle activity and spasms.
Main Results:
- Limited evidence currently exists regarding the benefits of BTX-A in reducing pain related to sub-pectoral tissue expanders.
- BTX-A, at doses like 100 units, has demonstrated the ability to reduce muscle activity and spasms.
Conclusions:
- Further research is needed to establish a consensus on the effectiveness of BTX-A for pain management in sub-pectoral breast reconstruction.
- BTX-A shows potential for alleviating implant-related muscle spasms and improving patient outcomes.
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
Local Anesthetics: Clinical Application as Spinal Anesthesia
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...

